General Pharmacology — MCQs

General Pharmacology Indian Medical PG Practice Questions and MCQs

Question 581: Propranolol is most commonly prescribed as first-line therapy for which condition?

A. Atrioventricular (AV) block
B. Hypertension (high blood pressure)
C. Cardiac arrest
D. Thyrotoxicosis (excessive thyroid hormones) (Correct Answer)

Explanation: ***Thyrotoxicosis (excessive thyroid hormones)*** - **Propranolol** is commonly prescribed as **first-line symptomatic therapy** for **thyrotoxicosis** to manage symptoms such as **tachycardia, tremors, palpitations, and anxiety**. - It works by **blocking peripheral conversion of T4 to T3** and providing rapid **symptomatic relief** through beta-blockade. - While it does not treat the underlying thyroid disorder, it is the **immediate first-line agent** for symptom control while definitive treatment (antithyroid drugs, radioiodine, or surgery) is being arranged. - **Clinical pearl:** Propranolol is preferred over selective beta-blockers due to its additional effect on T4 to T3 conversion. *Hypertension (high blood pressure)* - **Propranolol** is **NOT a first-line agent** for hypertension in current guidelines (JNC 8, ESC/ESH). - First-line agents include **ACE inhibitors, ARBs, thiazide diuretics, and calcium channel blockers**. - Non-selective beta-blockers like propranolol are typically **third-line or later** due to unfavorable metabolic effects and side effect profile. - Selective beta-blockers (atenolol, metoprolol) may be used in specific hypertension scenarios, but propranolol is rarely first-line. *Atrioventricular (AV) block* - **Propranolol** is **absolutely contraindicated** in **AV block** as it further slows conduction through the AV node. - Beta-blockers can precipitate **complete heart block** in patients with pre-existing conduction abnormalities. *Cardiac arrest* - **Propranolol** is **contraindicated** in acute management of **cardiac arrest** as it reduces cardiac contractility and can worsen outcomes. - Cardiac arrest management involves **CPR, defibrillation, epinephrine, and amiodarone**.

Question 582: Which of the following statements about glucocorticoids is true?

A. Glucocorticoids directly activate T-helper cells.
B. Glucocorticoids have no effect on immune cells.
C. Glucocorticoids downregulate MHC class II expression. (Correct Answer)
D. Glucocorticoids enhance the activity of cytotoxic T cells.

Explanation: ***Glucocorticoids downregulate MHC class II expression.*** - Glucocorticoids exert **immunosuppressive effects** by reducing the expression of **MHC class II molecules** on antigen-presenting cells. - This downregulation impairs the ability of antigen-presenting cells to activate **CD4+ T-helper cells**, thereby suppressing adaptive immune responses. *Glucocorticoids directly activate T-helper cells.* - Glucocorticoids do not directly activate T-helper cells; rather, they have an **inhibitory effect** on T-cell function and proliferation. - They tend to promote **T-cell apoptosis** and reduce cytokine production, thus dampening T-helper cell responses. *Glucocorticoids have no effect on immune cells.* - This statement is incorrect as glucocorticoids have profound and widespread **immunosuppressive and anti-inflammatory effects** on various immune cells. - They influence the function, proliferation, and survival of **lymphocytes, macrophages, and granulocytes**. *Glucocorticoids enhance the activity of cytotoxic T cells.* - Glucocorticoids generally **suppress immune responses**, including the activity of **cytotoxic T cells (CTLs)**, rather than enhancing it. - They tend to inhibit the production of **interleukins** necessary for CTL activation and proliferation.

Question 583: In ophthalmology, if a patient is allergic to aminoesters, which local anesthetic can be safely used?

A. Procaine
B. Cocaine
C. Prilocaine (Correct Answer)
D. Tetracaine

Explanation: **Local anesthetics are classified into two chemical groups: esters (aminoesters) and amides. Allergies to esters typically do not cross-react with amides.** ***Prilocaine*** - **Prilocaine** is an **amide-type local anesthetic**, and allergies to **aminoesters** typically do not cross-react with **amides**. - It is a safe alternative in patients with a known allergy to **ester-type local anesthetics**. *Cocaine* - **Cocaine** is an **ester-type local anesthetic**, sharing a similar chemical structure with **aminoesters**. - Patients allergic to **aminoesters** are likely to experience a **cross-reaction** with **cocaine**. *Procaine* - **Procaine** is a classic **ester-type local anesthetic** (an aminoester). - An allergy to aminoesters directly implies an allergy to **procaine** due to its chemical classification. *Tetracaine* - **Tetracaine** is also an **ester-type local anesthetic** (an aminoester). - It is contraindicated in patients with an allergy to **aminoesters** due to the high risk of **allergic reaction**.

Question 584: The mechanism by which ergometrine stops postpartum hemorrhage is that it:

A. Induces platelet aggregation
B. Promotes coagulation
C. Causes vasoconstriction of uterine arteries
D. Increases tone of uterine muscle (Correct Answer)

Explanation: ***Increases tone of uterine muscle*** - **Ergometrine** is an **ergot alkaloid** that directly stimulates **uterine smooth muscle contractions**. - These sustained contractions lead to **compression of blood vessels within the myometrium**, thereby reducing blood flow and controlling **postpartum hemorrhage**. *Causes vasoconstriction of uterine arteries* - While ergometrine does have some generalized **vasoconstrictive effects**, its primary mechanism of action in controlling postpartum hemorrhage is not mainly through direct vasoconstriction of large uterine arteries. - The crucial effect is the **sustained uterine contraction** which mechanically occludes blood vessels, rather than chemical constriction of the vessels themselves. *Induces platelet aggregation* - Ergometrine does not primarily act by inducing **platelet aggregation**; this is a function of specific clotting factors and platelet activators. - Its therapeutic effect against hemorrhage is mediated through its action on **uterine contractility**, not on the cellular components of coagulation. *Promotes coagulation* - Ergometrine does not directly promote the **coagulation cascade** or enhance the formation of fibrin clots. - Its mechanism of action is distinct from agents that affect intrinsic or extrinsic pathways of coagulation.

Question 585: Which drug is used in the treatment of Type I tyrosinemia?

A. Pemoline
B. Alogliptin
C. Milrinone
D. Nitisinone (Correct Answer)

Explanation: ***Nitisinone*** - **Nitisinone** (brand name Orfadin) is specifically approved for the treatment of **hereditary tyrosinemia type 1 (HT-1)**. - It works by inhibiting 4-hydroxyphenylpyruvate dioxygenase, an enzyme upstream of the deficient enzyme in HT-1, thereby reducing the production of toxic metabolites. *Alogliptin* - **Alogliptin** is a dipeptidyl peptidase-4 (DPP-4) inhibitor used in the management of **Type 2 diabetes mellitus**. - It helps to lower blood glucose levels by increasing the half-life of **incretin hormones**, which stimulate insulin release. *Pemoline* - **Pemoline** is a central nervous system (CNS) stimulant that was formerly used to treat **attention deficit hyperactivity disorder (ADHD)** and narcolepsy. - Its use has been largely discontinued due to concerns about its potential for **liver toxicity**. *Milrinone* - **Milrinone** is a phosphodiesterase-3 inhibitor used in the short-term management of **decompensated heart failure**. - It increases **cardiac contractility** and causes vasodilation, improving cardiac output.

Question 586: Which of the following is NOT a function of Prostaglandin E1 (PGE1)?

A. Plays a role in initiating puberty (Correct Answer)
B. Modulates inflammatory responses
C. Used in the management of erectile dysfunction
D. Maintains the patency of the ductus arteriosus

Explanation: ***Plays a role in initiating puberty*** - **Prostaglandin E1 (PGE1)** is primarily involved in smooth muscle relaxation, vasodilation, and inflammation, and does not have a direct role in initiating **puberty**. - The initiation of puberty is mainly controlled by the **hypothalamic-pituitary-gonadal (HPG) axis** and surge of **gonadotropin-releasing hormone (GnRH)**. *Used in the management of erectile dysfunction* - **PGE1 formulations** (alprostadil) are used as a topical or intracavernosal injection to treat **erectile dysfunction** by inducing vasodilation in the penis. - Its vasodilatory effects increase blood flow to the corpora cavernosa, leading to **penile erection**. *Modulates inflammatory responses* - **PGE1** is involved in **inflammatory processes**, often exerting both pro- and anti-inflammatory effects depending on the context and specific receptors activated. - It can help to **reduce inflammation** and pain, as well as influencing immune cell function. *Maintains the patency of the ductus arteriosus* - In newborns with **congenital heart defects**, **PGE1** is administered to maintain the **patency of the ductus arteriosus**, allowing for blood flow between the aorta and pulmonary artery. - This is crucial for conditions where pulmonary or systemic blood flow is dependent on a patent ductus, bridging the infant to surgery or other interventions.

Question 587: What is the mechanism of action of clofibrate in lipid metabolism?

A. Inhibits lipolysis in adipose tissue.
B. Inhibits HMG CoA reductase.
C. Binds bile acids and bile salts in the small intestine.
D. Increases lipoprotein lipase activity through PPAR alpha, leading to enhanced lipolysis of triglycerides. (Correct Answer)

Explanation: ***Increases lipoprotein lipase activity through PPAR alpha, leading to enhanced lipolysis of triglycerides.*** - Clofibrate, a **fibrat**e, acts as an agonist for **peroxisome proliferator-activated receptor alpha (PPAR-α)**. - Activation of PPAR-α leads to increased synthesis of **lipoprotein lipase (LPL)**, which enhances the breakdown of **triglycerides** in VLDL particles. *Inhibits lipolysis in adipose tissue.* - This mechanism is characteristic of **niacin (nicotinic acid)**, which reduces the release of free fatty acids from adipose tissue. - Clofibrate's primary action is not focused on inhibiting lipolysis in adipose tissue. *Inhibits HMG CoA reductase.* - This is the mechanism of action for **statins** (e.g., simvastatin, atorvastatin), which are used to reduce cholesterol synthesis. - Clofibrate does not directly inhibit HMG CoA reductase. *Binds bile acids and bile salts in the small intestine.* - This mechanism is characteristic of **bile acid sequestrants** (e.g., cholestyramine, colestipol). - These drugs prevent the reabsorption of bile acids, leading to increased cholesterol conversion to bile acids in the liver.

Question 588: Which of the following is NOT typically produced by local anesthetics?

A. Muscle relaxation
B. Euphoria
C. Dysphoria (Correct Answer)
D. Analgesia

Explanation: Detailed Analysis: ***Dysphoria*** - While local anesthetics can cause a range of central nervous system effects with toxicity, **dysphoria** (a state of unease or generalized dissatisfaction with life) is not a typical or primary direct effect of their action on receptors. High doses or systemic absorption might lead to anxiety and restlessness, but dysphoria specifically is uncommon. - The primary mechanism of local anesthetics involves blocking **voltage-gated sodium channels** [1], leading to a reversible loss of sensation, not directly causing mood disturbances like dysphoria. *Euphoria* - **Euphoria** can sometimes be observed with systemic local anesthetic toxicity due to initial CNS stimulation before depression. Some individuals report a transient feeling of well-being or altered mental status with high systemic levels of certain local anesthetics. - This effect is not a direct therapeutic goal but rather an **adverse reaction** associated with systemic absorption and CNS excitation. *Analgesia* - **Analgesia** is the primary therapeutic effect of local anesthetics, achieved by blocking nerve impulse transmission. This prevents the sensation of pain from reaching the brain [1]. - They work by **blocking sodium channels** in nerve membranes [1], thereby inhibiting the initiation and propagation of action potentials [2]. *Muscle relaxation* - **Muscle relaxation** in the area of blockade is a direct consequence of the local anesthetic's action on the motor nerves supplying the muscles. - By blocking nerve conduction in **motor nerve fibers** [1], local anesthetics prevent muscle contraction, leading to temporary skeletal muscle paralysis.

Question 589: Beta2-agonists cause all except:

A. Hyperkalemia (Correct Answer)
B. Hyperglycemia
C. Tremor
D. Palpitation

Explanation: ***Hyperkalemia*** - Beta2-agonists actually cause **hypokalemia**, not hyperkalemia, by promoting the intracellular shift of potassium. - This effect is due to the stimulation of the **Na+/K+-ATPase pump** by beta-2 adrenergic receptors. *Hyperglycemia* - Beta2-agonists can lead to **hyperglycemia** by promoting glycogenolysis and gluconeogenesis in the liver. - They also decrease **insulin secretion** and increase insulin resistance. *Tremor* - **Tremor** is a common side effect of beta2-agonists, particularly in the hands, due to direct stimulation of beta2 receptors on skeletal muscle. - This muscle stimulation leads to increased muscle twitching and a fine tremor. *Palpitation* - **Palpitations** can occur due to the systemic absorption of beta2-agonists, leading to activation of beta1 receptors in the heart. - This can cause **tachycardia** and a sensation of a racing heart.

Question 590: What is the appropriate diluent for the BCG vaccine?

A. Sterile normal saline
B. Sterile distilled water (Correct Answer)
C. Sterile dextrose solution
D. Colloid solutions

Explanation: ***Sterile distilled water*** - **Sterile distilled water** is the recommended diluent for the **BCG vaccine** to ensure proper reconstitution and antigen stability. - Using the correct diluent is critical for maintaining the **efficacy** and safety of the vaccine. *Sterile normal saline* - **Sterile normal saline** (0.9% NaCl) can be used as a diluent for some vaccines, but it is **not appropriate for BCG** as it can negatively impact vaccine viability. - The **salt concentration** in saline can affect the live attenuated organisms in the BCG vaccine. *Sterile dextrose solution* - **Dextrose solutions** are generally avoided as vaccine diluents due to their potential to support **bacterial growth** or alter vaccine stability. - They are primarily used for **intravenous fluid administration** and not for vaccine reconstitution. *Colloid solutions* - **Colloid solutions** like albumin or dextran are never used as vaccine diluents as they can interfere with the **vaccine antigens** and cause adverse reactions. - These solutions are typically used for **plasma volume expansion** and have no role in vaccine preparation.

Practice by Chapter

Pharmacokinetics: Absorption and Distribution

Practice Questions

Pharmacokinetics: Metabolism and Excretion

Practice Questions

Pharmacodynamics and Receptor Theory

Practice Questions

Drug-Receptor Interactions and Dose-Response

Practice Questions

Pharmacogenetics and Personalized Medicine

Practice Questions

Adverse Drug Reactions and Toxicity

Practice Questions

Drug Interactions

Practice Questions

Drug Development and Regulation

Practice Questions

Pediatric and Geriatric Pharmacology

Practice Questions

Placental Transfer and Lactation

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free